These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30883600)

  • 1. Correction: Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients.
    Dargham SR; Zahirovic S; Hammoudeh M; Al Emadi S; Masri BK; Halabi H; Badsha H; Uthman I; Mahfoud ZR; Ashour H; El Haq WG; Bayoumy K; Kapiri M; Saxena R; Plenge RM; Kazkaz L; Arayssi T
    PLoS One; 2019; 14(3):e0214258. PubMed ID: 30883600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.
    Gomides APM; de Albuquerque CP; Santos ABV; Amorim RBC; Bértolo MB; Júnior PL; Santos IA; Giorgi RDN; Sacilotto NC; Radominski SC; Borghi FM; Guimarães MFBR; Pinto MRDC; Resende GG; Bonfiglioli KR; Silva HCD; Sauma MFLDC; Sauma ML; de Medeiros JB; Pereira IA; de Castro GRW; Brenol CV; Xavier RM; da Mota LMH; Pinheiro GDRC
    PLoS One; 2019; 14(4):e0215198. PubMed ID: 30947308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
    Crowson CS; Rollefstad S; Kitas GD; van Riel PL; Gabriel SE; Semb AG;
    PLoS One; 2017; 12(4):e0175605. PubMed ID: 28388688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis.
    Sung YK; Yoshida K; Prince FHM; Frits ML; Cho SK; Choe JY; Lee HS; Lee J; Lee SS; Yoo DH; Helfgott SM; Shadick NA; Weinblatt ME; Solomon DH; Bae SC
    PLoS One; 2019; 14(8):e0221314. PubMed ID: 31412077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    Jeong H; Baek SY; Kim SW; Eun YH; Kim IY; Kim H; Lee J; Koh EM; Cha HS
    PLoS One; 2017; 12(5):e0178309. PubMed ID: 28542532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis.
    Yang B; Huang Z; Feng W; Wei W; Zhang J; Liao Y; Li L; Liu X; Wu Z; Cai B; Bai Y; Wang L
    PLoS One; 2017; 12(3):e0173531. PubMed ID: 28253339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis-A Meta-Analysis.
    Fisher A; Bassett K; Goel G; Stanely D; Brookhart MA; Freeman HJ; Wright JM; Dormuth CR
    PLoS One; 2017; 12(2):e0172646. PubMed ID: 28199406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.
    Tokai N; Yoshida S; Kotani T; Yoshikawa A; Kimura Y; Fujiki Y; Matsumura Y; Takeuchi T; Makino S; Arawaka S
    PLoS One; 2019; 14(1):e0211750. PubMed ID: 30699195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Chronic Hepatitis C Virus Infection Is Associated with the Development of Rheumatoid Arthritis: A Nationwide Population-Based Study in Taiwan.
    Su FH; Wu CS; Sung FC; Chang SN; Su CT; Shieh YH; Yeh CC
    PLoS One; 2016; 11(11):e0166508. PubMed ID: 27829054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.
    Pan Y; Norton S; Gwinnutt JM; Kearsley-Fleet L; Symmons DPM; Lunt M; Young A; ; Hyrich KL; Verstappen SMM
    PLoS One; 2020; 15(4):e0231481. PubMed ID: 32240271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis.
    Baghdadi LR
    PLoS One; 2020; 15(12):e0243960. PubMed ID: 33296441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study.
    Raknes G; Småbrekke L
    PLoS One; 2019; 14(10):e0223545. PubMed ID: 31574126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: (In)Visible illness: A photovoice study of the lived experience of self-managing rheumatoid arthritis.
    Donnelly S; Wilson AG; Mannan H; Dix C; Whitehill L; Kroll T
    PLoS One; 2021; 16(4):e0250451. PubMed ID: 33852646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.
    Choi S; Lee KH
    PLoS One; 2018; 13(6):e0199468. PubMed ID: 29912956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction to Expression of Concern on: Functional Improvement of Regulatory T Cells from Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan.
    PLOS ONE Staff
    PLoS One; 2021; 16(3):e0249512. PubMed ID: 33780509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.
    Moots RJ; Xavier RM; Mok CC; Rahman MU; Tsai WC; Al-Maini MH; Pavelka K; Mahgoub E; Kotak S; Korth-Bradley J; Pedersen R; Mele L; Shen Q; Vlahos B
    PLoS One; 2017; 12(6):e0179308. PubMed ID: 28582423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Epidemiology of Tuberculosis in Immigrants in a Large City with Large-Scale Immigration (1991-2013).
    Ospina JE; Orcau À; Millet JP; Ros M; Gil S; Caylà JA;
    PLoS One; 2020; 15(9):e0238963. PubMed ID: 32881939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates.
    Guinea J; Escribano P; Vena A; Muñoz P; Martínez-Jiménez MDC; Padilla B; Bouza E
    PLoS One; 2020; 15(2):e0229347. PubMed ID: 32049980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: "Epidemiology and aetiology of influenza-like illness among households in metropolitan Vientiane, Lao PDR": A prospective, community-based cohort study.
    Rudge JW; Inthalaphone N; Pavlicek R; Paboriboune P; Flaissier B; Monidarin C; Steenkeste N; Davong V; Vongsouvath M; Bonath KA; Messaoudi M; Saadatian-Elahi M; Newton P; Endtz H; Dance D; Paranhos Baccala G; Sanchez Picot V
    PLoS One; 2019; 14(4):e0216491. PubMed ID: 31039210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Temporal Patterns of Larval Fish Occurrence in a Large Subtropical River.
    Shuai F; Li X; Li Y; Li J; Yang J; Lek S
    PLoS One; 2016; 11(5):e0156556. PubMed ID: 27227335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.